{"symbol": "IMMU", "companyName": "Immunomedics Inc.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.immunomedics.com", "description": "Immunomedics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.", "CEO": "Michael F. Pehl", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}